BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38139092)

  • 1. Sphingomyelin Metabolism Modifies Luminal A Breast Cancer Cell Line under a High Dose of Vitamin C.
    Codini M; Fiorani F; Mandarano M; Cataldi S; Arcuri C; Mirarchi A; Ceccarini MR; Beccari T; Kobayashi T; Tomishige N; Sidoni A; Albi E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells.
    Nehdi A; Ali R; Alhallaj A; Alzahrani H; Samman N; Mashhour A; Baz O; Barhoumi T; Alghanem B; Khan A; Alriyees L; Boudjelal M
    Molecules; 2019 May; 24(11):. PubMed ID: 31141879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
    Khazaei S; Nilsson L; Adrian G; Tryggvadottir H; Konradsson E; Borgquist S; Isaksson K; Ceberg C; Jernström H
    Oncotarget; 2022; 13():439-453. PubMed ID: 35222809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TNF-α regulates the proliferation of human breast cancer cells via regulation of ceramide content].
    Lyu Y; Xu X; Yun J; Yi J; Li X; Liu X; Ling R; Wang L; Fan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1303-1309. PubMed ID: 29169412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
    Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
    Song W; Thakor P; Vesey DA; Gobe GC; Morais C
    Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Cholesterol in MCF7 Human Breast Cancer Cells.
    Albi E; Mandarano M; Cataldi S; Ceccarini MR; Fiorani F; Beccari T; Sidoni A; Codini M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells.
    Chen X; Ma N; Zhou Z; Wang Z; Hu Q; Luo J; Mei X; Yang Z; Zhang L; Wang X; Feng Y; Yu X; Ma J; Guo X
    Med Sci Monit; 2017 Jun; 23():2674-2683. PubMed ID: 28570501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.
    Lee SJ; Jeong JH; Lee IH; Lee J; Jung JH; Park HY; Lee DH; Chae YS
    Anticancer Res; 2019 Feb; 39(2):751-758. PubMed ID: 30711954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231.
    Garbar C; Mascaux C; Giustiniani J; Merrouche Y; Bensussan A
    Sci Rep; 2017 Aug; 7(1):7201. PubMed ID: 28775276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways.
    Wu CW; Liu HC; Yu YL; Hung YT; Wei CW; Yiang GT
    Oncol Rep; 2017 Apr; 37(4):2177-2184. PubMed ID: 28259996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
    Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
    Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
    Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
    Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines.
    Guerriero E; Sorice A; Capone F; Napolitano V; Colonna G; Storti G; Castello G; Costantini S
    PLoS One; 2014; 9(12):e115287. PubMed ID: 25531443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin.
    Zheng K; Chen Z; Feng H; Chen Y; Zhang C; Yu J; Luo Y; Zhao L; Jiang X; Shi F
    Cell Death Dis; 2019 Feb; 10(3):157. PubMed ID: 30770781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.